GN Store Nord consensus picture on Tuesday, shares on Copenhagen in focus
Published on 06/30/2026 at 10:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-30, 10:20.
GN Store Nord (DK0010272632) starts Tuesday trading on the Copenhagen exchange with investors focused on the analyst consensus for the hearing-aid and audio-technology specialist. The stock is part of the European hearing sector alongside peers such as Demant and Sonova, which are closely tracked by institutional investors across the region.
What the consensus indicates
Analyst coverage on GN Store Nord typically centers on organic growth in hearing-aid units, profitability in the audio segment and progress on cost-efficiency programs. Research houses commonly frame their recommendations around margin development and cash generation relative to sector peers Demant, Sonova and Amplifon.
Forecast models for GN Store Nord generally incorporate assumptions on volume growth in key markets such as Europe and North America, as well as pricing and mix effects in premium hearing aids and enterprise headsets. Earnings expectations also reflect investment needs in research and development for new chip platforms and wireless technologies.
How analysts evaluate the stock
In their assessments of GN Store Nord, analysts regularly compare valuation metrics such as price-earnings ratios, enterprise value to EBITDA and free-cash-flow yields with Demant, Sonova and other listed medical-technology names. They pay particular attention to whether GN Store Nord trades at a discount or premium to this group and how that relates to its medium-term growth outlook.
Recommendation wording from larger international and Nordic banks often combines a rating label such as Buy, Hold or Sell with a 12-month price target that reflects their scenario for revenue growth and margin improvement. Changes to these targets can follow quarterly reports, guidance updates or sector news on reimbursement and regulation.
Background and price data on GN Store Nord
Further company news, historical articles and price information on GN Store Nord can be found in the dedicated topic area and on the company’s investor-relations pages.
The business behind the stock
GN Store Nord generates its revenue primarily through hearing aids, hearing implants and audio solutions such as headsets and speakerphones. Under the GN Hearing and GN Audio divisions, the company sells products including ReSound-branded hearing aids and Jabra-branded headsets to consumers and enterprise customers worldwide.
Where the stock trades today
GN Store Nord shares (DK0010272632) trade on 2026-06-30, 10:20, on the Copenhagen exchange in Danish kroner, with the stock following the broader European hearing-aid sector trend.
© AD HOC NEWS - This article is for informational purposes only and does not constitute investment advice, investment recommendation or an offer to buy or sell securities. All information is provided without guarantee; investors should consult qualified advisers before making investment decisions.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
